Total Payments
$92,124
2024 Payments
$8,865
Companies
30
Transactions
366
Medicare Patients
6,414
Medicare Billing
$743,829
Payment Breakdown by Category
Other$81,875 (88.9%)
Food & Beverage$5,980 (6.5%)
Travel$2,469 (2.7%)
Consulting$1,800 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $81,875 | 50 | 88.9% |
| Food and Beverage | $5,980 | 292 | 6.5% |
| Travel and Lodging | $2,469 | 19 | 2.7% |
| Consulting Fee | $1,800 | 5 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $84,058 | 158 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $4,794 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $714.59 | 108 | $0 (2023) |
| ABIOMED | $401.51 | 5 | $0 (2024) |
| Abbott Laboratories | $332.90 | 3 | $0 (2024) |
| Boston Scientific Corporation | $191.77 | 4 | $0 (2020) |
| CVRx, Inc. | $177.42 | 1 | $0 (2021) |
| Medtronic, Inc. | $166.21 | 3 | $0 (2024) |
| Amgen Inc. | $153.17 | 11 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $127.85 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,865 | 18 | Janssen Pharmaceuticals, Inc ($8,416) |
| 2023 | $4,521 | 29 | Janssen Pharmaceuticals, Inc ($3,967) |
| 2022 | $21,613 | 114 | Janssen Pharmaceuticals, Inc ($21,088) |
| 2021 | $19,665 | 68 | Janssen Pharmaceuticals, Inc ($19,187) |
| 2020 | $8,079 | 30 | Janssen Pharmaceuticals, Inc ($7,912) |
| 2019 | $12,110 | 47 | Janssen Pharmaceuticals, Inc ($8,443) |
| 2018 | $4,329 | 24 | Janssen Pharmaceuticals, Inc ($3,614) |
| 2017 | $12,942 | 36 | Janssen Pharmaceuticals, Inc ($11,430) |
All Payment Transactions
366 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $34.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Stents | ||||||
| 08/08/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: Cardiovascular | ||||||
| 07/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $146.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Renal Denervation System | ||||||
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,030.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $132.56 | General |
| Category: Renal Denervation System | ||||||
| 03/13/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $137.18 | General |
| Category: Heart Failure | ||||||
| 03/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.36 | General |
| Category: Cardiovascular | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $24.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $126.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Cardiovascular | ||||||
| 12/15/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.10 | General |
| Category: Cardiovascular | ||||||
| 12/15/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.74 | General |
| Category: Cardiovascular | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $56.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $149.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/01/2023 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $89.37 | General |
| Category: DEVICES | ||||||
| 11/30/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $146.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,761 | 3,378 | $1.8M | $214,052 |
| 2022 | 17 | 1,687 | 3,145 | $1.5M | $190,498 |
| 2021 | 16 | 1,555 | 2,735 | $1.4M | $186,055 |
| 2020 | 15 | 1,411 | 2,202 | $444,400 | $153,225 |
Total Patients
6,414
Total Services
11,460
Medicare Billing
$743,829
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 505 | 1,041 | $869,808 | $109,075 | 12.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 108 | 205 | $187,727 | $20,562 | 11.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 537 | 1,121 | $111,669 | $13,789 | 12.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 99 | 170 | $80,400 | $11,658 | 14.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 64 | 256 | $129,288 | $11,027 | 8.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 63 | 63 | $46,246 | $9,746 | 21.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 144 | 145 | $68,878 | $8,176 | 11.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 40 | $50,285 | $5,863 | 11.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 23 | $42,562 | $5,554 | 13.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 27 | $59,338 | $4,979 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 30 | $35,332 | $4,783 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 51 | $30,336 | $3,111 | 10.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $23,178 | $3,040 | 13.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $14,528 | $1,728 | 11.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 129 | $3,447 | $541.80 | 15.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 37 | 39 | $13,626 | $420.42 | 3.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 520 | 1,058 | $892,642 | $111,083 | 12.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 575 | 1,189 | $114,300 | $14,356 | 12.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 118 | 200 | $90,400 | $12,028 | 13.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 118 | $76,582 | $9,733 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 121 | $72,563 | $8,222 | 11.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 36 | 144 | $56,016 | $6,979 | 12.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $37,650 | $4,663 | 12.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 74 | 74 | $35,616 | $4,174 | 11.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $33,945 | $3,627 | 10.7% |
About Dr. David Schaer, MD
Dr. David Schaer, MD is a Internal Medicine healthcare provider based in East Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205892809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Schaer, MD has received a total of $92,124 in payments from pharmaceutical and medical device companies, with $8,865 received in 2024. These payments were reported across 366 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($81,875).
As a Medicare-enrolled provider, Schaer has provided services to 6,414 Medicare beneficiaries, totaling 11,460 services with total Medicare billing of $743,829. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology, Cardiovascular Disease
- Location East Brunswick, NJ
- Active Since 04/22/2006
- Last Updated 04/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205892809
Products in Payments
- XARELTO (Drug) $84,058
- ELIQUIS (Drug) $4,536
- ENTRESTO (Drug) $690.99
- Impella (Device) $401.51
- CAMZYOS (Drug) $257.44
- Quadra Assura CRT Defibrillator (Device) $180.19
- Barostim Neo System (Device) $177.42
- SYMPLICITY G3 (Device) $152.58
- GENERAL THERAPIES (Device) $139.49
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $137.18
- Resolute (Device) $120.46
- IGT Devices Und (Device) $112.85
- VERQUVO (Drug) $102.82
- Repatha (Biological) $95.35
- CARDIVA VASCADE 6/7F VCS (Device) $89.37
- Aggrastat (tirofiban HCl) (Drug) $80.22
- Edarbi (Drug) $66.14
- Corlanor (Drug) $57.82
- GENERAL - STENTS (Device) $47.37
- PRALUENT ALIROCUMAB INJECTION (Biological) $47.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Brunswick
Aamer Farooq, Md, MD
Internal Medicine — Payments: $19,081
Internal Medicine $19,081
Dr. Lev Simkhayev, M.d, M.D
Internal Medicine — Payments: $11,458
Internal Medicine $11,458
Dr. Ahab Gabriel
Internal Medicine — Payments: $8,656
Internal Medicine $8,656
Sarath Babu, Md, MD
Internal Medicine — Payments: $8,399
Internal Medicine $8,399
Scott Yager, M.d, M.D
Internal Medicine — Payments: $8,091
Internal Medicine $8,091
Jenny Liu, Md, Ms, MD, MS
Internal Medicine — Payments: $7,952
Internal Medicine $7,952